
ISCT 2023 Paris Annual Meeting
Read More
Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing
Read More
Where is innovation needed in cell therapy?
Read More
Beyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins
Read More
GEN: Cell and Gene Therapy Scale-Up Challenges
Read More
No More Sleepwalking: New Mindsets for Manufacturing Cell and Gene Therapies at Commercial Scale
Read MoreTTP introduces cellular origins a TTP company focussed on delivering scalable manufacture of cell and gene therapies
Read More
What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development
Read More
UK Innovation corridor ‘critical’ to development of cell and gene therapy, TTP plc summit told
Read More
Video Interview: Talking Cell Therapy Trends – Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies
Read More
Medicine Maker: How do we ensure that not only the rich benefit from cell and gene therapy?
Read More
What can our experience of traditional bioprocessing teach us about the manufacturing of new cell therapies?
Read More
Predicting failure rates in cell therapy manufacturing is one in a million good enough
Read More
GEN: Technological Advances Facilitate Autologous Cell Therapy Scale-Out
Read More
Who should lead the charge in cell therapy manufacturing
Read More
Cell therapy scaling beyond the biology
Read MoreAs featured in:
Sign up for updates.
Stay up-to-date with Cellular Origins and our modular factory automation for cell and gene therapies.